跳至主要内容
临床试验/ISRCTN13784514
ISRCTN13784514已完成未知

A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF)

Hull and East Yorkshire Hospitals NHS Trust0 个研究点目标入组 50 人开始时间: 2018年7月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

2019 protocol in https://pubmed.ncbi.nlm.nih.gov/31649946/ (added 01/06/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Males and females aged =50 years. This age cut-off is chosen because IPF is very rare under 50 years of age making an alternative diagnosis likely
  • 2. IPF diagnosed by multidisciplinary team (MDT) consensus in accordance with international guidelines
  • 3. mMRC dyspnoea grades 3 or 4 despite optimal management
  • 4. Oxygen saturation =90% on air/using usual oxygen prescription
  • 5. Able to give informed consent

排除标准

  • 1. Significant comorbid cardiorespiratory disease other than IPF considered by the principal investigator to be the primary cause of breathlessness
  • 2. Pulmonary rehabilitation: completed < = 3 months previously
  • 3. Breathlessness clinic attendance: completed < = 3 months previously
  • 4. Unwilling or unable to consent or complete study measures

研究者

发起方
Hull and East Yorkshire Hospitals NHS Trust

相似试验